Hashem, H.E.; Amr, A.E.-G.E.; Almehizia, A.A.; Naglah, A.M.; Kariuki, B.M.; Eassa, H.A.; Nossier, E.S.
Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies. Molecules 2023, 28, 7252.
https://doi.org/10.3390/molecules28217252
AMA Style
Hashem HE, Amr AE-GE, Almehizia AA, Naglah AM, Kariuki BM, Eassa HA, Nossier ES.
Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies. Molecules. 2023; 28(21):7252.
https://doi.org/10.3390/molecules28217252
Chicago/Turabian Style
Hashem, Heba E., Abd El-Galil E. Amr, Abdulrahman A. Almehizia, Ahmed M. Naglah, Benson M. Kariuki, Heba A. Eassa, and Eman S. Nossier.
2023. "Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies" Molecules 28, no. 21: 7252.
https://doi.org/10.3390/molecules28217252
APA Style
Hashem, H. E., Amr, A. E. -G. E., Almehizia, A. A., Naglah, A. M., Kariuki, B. M., Eassa, H. A., & Nossier, E. S.
(2023). Nanoparticles of a Pyrazolo-Pyridazine Derivative as Potential EGFR and CDK-2 Inhibitors: Design, Structure Determination, Anticancer Evaluation and In Silico Studies. Molecules, 28(21), 7252.
https://doi.org/10.3390/molecules28217252
